Treating patients with low high-density lipoprotein cholesterol: choices, issues and opportunities

Three clinical trials have recently focused on the benefits of lipid-regulating therapy in populations with normocholesterolaemia and low high-density lipoprotein (HDL)-cholesterol. Two secondary prevention studies (Veterans Affairs HDL-Cholesterol Intervention Trial [VA-HIT] and Bezafibrate Infarct...

Descripción completa

Detalles Bibliográficos
Autor principal: Watts, Gerald F
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59631/
https://www.ncbi.nlm.nih.gov/pubmed/11806784
http://dx.doi.org/10.1186/cvm-2-3-118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59631/
https://www.ncbi.nlm.nih.gov/pubmed/11806784
http://dx.doi.org/10.1186/cvm-2-3-118

Ejemplares similares